

## `index.qmd`
- Introduction — — *.unnumbered*
    - Why Foundation Models for Genomics? —
    - Recurring Themes —
    - Typography and Formatting — — *.unnumbered*
    - Structure and Organization —
    - A Framework, Not a Snapshot —

## `preface.qmd`
- Preface — — *.unnumbered*
    - Why I Wrote This Book —
    - How This Book Came Together —
    - How to Read This Book —
    - What This Book Assumes (and What It Does Not) —
    - A Note on Scope and Opinions —
    - Acknowledgements —

## `p1--foundations.qmd`
- Part I: Data Foundations — — *.unnumbered*

## `p1-ch01-ngs.qmd`
- From Reads to Variants — `@ch01-ngs`
    - NGS Data Challenges — `@ch01-challenges`
    - Targeting Strategies: Panels, Exomes, and Genomes — `@ch01-targeting`
        - Targeted and Panel Sequencing — `@ch01-panels`
        - Whole-Exome Sequencing — `@ch01-wes`
        - Whole-Genome Sequencing — `@ch01-wgs`
        - Long-Read Sequencing Technologies — `@ch01-longread`
    - Classical Variant Calling Pipelines — `@ch01-classical`
        - From Sequencer to Aligned Reads — `@ch01-alignment`
        - Per-Sample Variant Calling — `@ch01-persample`
        - Cohort Calling and Filtering — `@ch01-cohort`
        - Sample-Level Quality Control — `@ch01-qc`
    - Haplotype Phasing — `@ch01-phasing`
        - Clinical and Analytical Importance — `@ch01-phasing-importance`
        - Phasing Methods — `@ch01-phasing-methods`
        - Phasing Approaches — `@ch01-phasing-approaches`
        - Genotype Imputation and Refinement — `@ch01-imputation`
        - Hybrid Sequencing and Coverage Boosting — `@ch01-hybrid`
    - Sources of Error and Uncertainty — `@ch01-errors`
        - Mapping Ambiguity and Reference Bias — `@ch01-mapping-bias`
        - Systematic Sequencing Artifacts — `@ch01-artifacts`
        - Coverage Gaps and Allelic Imbalance — `@ch01-coverage`
        - Complex Variants and Representation — `@ch01-complex`
    - Difficult Regions: The Limits of Short-Read Calling — `@ch01-difficult`
        - Segmental Duplications and Gene Families — `@ch01-segdup`
        - Low-Complexity and Repetitive Sequence — `@ch01-repeats`
        - HLA Region Complexity — `@ch01-hla`
    - Benchmarking and Ground Truth — `@ch01-benchmarks`
        - GIAB Reference Samples — `@ch01-giab`
        - Metrics and Their Meaning — `@ch01-metrics`
        - Limitations of Benchmarks — `@ch01-benchmark-limits`
    - DeepVariant: Variant Calling as Image Classification — `@ch01-deepvariant`
        - Pileup Images as Input — `@ch01-pileup`
        - Architecture and Training — `@ch01-deepvariant-arch`
        - Cohort Calling with GLnexus — `@ch01-glnexus`
        - Comparison with Classical Approaches — `@ch01-deepvariant-comparison`
    - Implications for Genomic Deep Learning — `@ch01-implications`
        - Variants as Atomic Units — `@ch01-atomic`
        - Inherited Biases and Blind Spots — `@ch01-inherited`
        - Effect Sizes Across the Frequency Spectrum — `@ch01-effect-sizes`
    - Reliability Landscape — `@ch01-reliability`

## `p1-ch02-data.qmd`
- Data Landscape — `@ch02-data`
    - Reference Genomes and Gene Annotations — `@ch02-reference`
        - Reference Assemblies — `@ch02-reference-assemblies`
        - Gene Models — `@ch02-gene-models`
    - Population Variant Catalogs and Allele Frequencies — `@ch02-population`
        - dbSNP and Variant Identifiers — `@ch02-dbsnp`
        - 1000 Genomes and Early Reference Panels — `@ch02-1000genomes`
        - Genome Aggregation Database (gnomAD) — `@ch02-gnomad`
    - Biobanks and GWAS Data — `@ch02-biobanks`
        - Large Population Cohorts — `@ch02-cohorts`
        - GWAS Summary Statistics — `@ch02-gwas-summary`
    - Functional Genomics and Regulatory Landscapes — `@ch02-functional`
        - ENCODE, Roadmap, and Related Consortia — `@ch02-encode`
        - Cistrome Data Browser — `@ch02-cistrome`
        - From Assays to Training Labels — `@ch02-assays-labels`
        - Deep Mutational Scanning and Multiplexed Variant Assays — `@ch02-dms`
    - Expression and eQTL Resources — `@ch02-expression`
        - Bulk Expression Atlases — `@ch02-gtex`
        - Single-Cell and Context-Specific Expression — `@ch02-single-cell`
    - Protein Databases — `@ch02-protein-databases`
        - Sequence Databases — `@ch02-protein-sequence`
        - Structure Databases — `@ch02-protein-structure`
    - Phenotype Definition and Data Quality — `@ch02-phenotypes`
        - Problem of Binary Disease Definitions — `@ch02-binary-phenotypes`
        - Electronic Health Record Quality and Completeness — `@ch02-ehr`
        - Coding Inconsistencies and Label Noise — `@ch02-label-noise`
        - Deep Phenotyping Approaches — `@ch02-deep-phenotyping`
        - Impact on Downstream Modeling — `@ch02-phenotype-impact`
    - Variant Interpretation Databases and Clinical Labels — `@ch02-clinical`
        - ClinVar and Clinical Assertions — `@ch02-clinvar`
        - Complementary Clinical Databases — `@ch02-clinical-other`
        - ClinGen and Expert Curation — `@ch02-clingen`
        - Pharmacogenomics Resources — `@ch02-pharmacogenomics`
    - Inherited Constraints — `@ch02-constraints`

## `p1-ch03-gwas.qmd`
- GWAS and Polygenic Scores — `@ch03-gwas`
    - GWAS Framework — `@ch03-gwas-framework`
        - Association Models for Quantitative Traits — `@ch03-linear-models`
        - Association Models for Disease Outcomes — `@ch03-logistic-models`
        - Manhattan Plots and Q-Q Plots — `@ch03-visualization`
        - Population Structure Control — `@ch03-population-structure`
    - Heritability: What Genetics Can Explain — `@ch03-heritability`
        - Pedigree Heritability — `@ch03-pedigree-heritability`
        - SNP-Heritability and the Missing Heritability Problem — `@ch03-snp-heritability`
        - Implications for GWAS and Polygenic Scores — `@ch03-heritability-implications`
    - Linkage Disequilibrium and the Association-Causation Gap — `@ch03-ld`
        - Structure of Linkage Disequilibrium — `@ch03-ld-structure`
        - Causal Variants, Tag Variants, and GWAS Catalogs — `@ch03-causal-vs-tag`
    - Fine-Mapping: From Loci to Causal Variants — `@ch03-fine-mapping`
        - Statistical Framework — `@ch03-fine-mapping-stats`
        - Functional Annotation Priors — `@ch03-functional-priors`
        - Multi-Ancestry Fine-Mapping — `@ch03-multi-ancestry-fine-mapping`
    - Polygenic Score Construction — `@ch03-pgs-construction`
        - Clumping and Thresholding — `@ch03-clumping-thresholding`
        - LD-Aware Bayesian Methods — `@ch03-bayesian-pgs`
        - Fine-Mapping-Informed Scores — `@ch03-fine-mapping-informed-pgs`
    - Polygenic Score Interpretation — `@ch03-pgs-interpretation`
        - Relative Risk and Percentiles — `@ch03-relative-risk`
        - Absolute Risk — `@ch03-absolute-risk`
        - Explained Variance and Discrimination — `@ch03-variance-discrimination`
    - Ancestry, Portability, and Fairness — `@ch03-portability`
        - Portability Problem — `@ch03-portability-problem`
        - Fairness and Health Equity — `@ch03-fairness`
    - Phenome-Wide Association Studies — `@ch03-phewas`
        - PheWAS Framework — `@ch03-phewas-framework`
        - PheWAS for Polygenic Score Interpretation — `@ch03-prs-phewas`
        - Phenotype Quality and PheWAS Power — `@ch03-phenotype-quality`
        - Deep Phenotyping and Embedding-Enhanced GWAS — `@ch03-deep-phenotyping`
    - From Association to Mechanism — `@ch03-mechanism`

## `p1-ch04-vep-classical.qmd`
- Classical Variant Prediction — `@ch04-vep-classical`
    - Conservation-Based Approaches — `@ch04-conservation`
        - Evolutionary Constraint Metrics — `@ch04-constraint-metrics`
        - What Conservation Measures Versus What Clinicians Need — `@ch04-conservation-clinical-gap`
        - Clinical Application and Boundaries — `@ch04-conservation-boundaries`
        - ACMG-AMP Variant Classification Framework —
    - Protein-Level Predictors — `@ch04-protein-predictors`
        - *SIFT*: Sequence Homology as Functional Constraint — `@ch04-sift`
        - *PolyPhen-2*: Integrating Structure and Sequence — `@ch04-polyphen`
        - From Sequence to Function — `@ch04-sequence-to-function`
        - Boundaries of Protein-Level Prediction — `@ch04-protein-boundaries`
    - *CADD* Framework — `@ch04-cadd`
        - Evolutionary Proxy Training and Label Sources — `@ch04-cadd-training`
        - Feature Integration — `@ch04-cadd-features`
        - Model Architecture and Scoring — `@ch04-cadd-scoring`
        - Evolutionary Proxy Problem — `@ch04-proxy-problem`
    - Other Ensemble Methods — `@ch04-ensemble-methods`
        - *REVEL* — `@ch04-revel`
        - *M-CAP* — `@ch04-mcap`
        - Comparison and Selection — `@ch04-ensemble-comparison`
    - Circularity and Ascertainment Bias — `@ch04-circularity`
        - Circularity Problem — `@ch04-circularity-definition`
        - Ascertainment Bias — `@ch04-ascertainment`
        - Implications for Clinical Use — `@ch04-clinical-implications`
    - Limitations of the Feature Engineering Paradigm — `@ch04-feature-limitations`
        - Feature Ceiling — `@ch04-feature-ceiling`
        - Limited Context — `@ch04-limited-context`
        - Persistent Gap Between Measurement and Need — `@ch04-measurement-gap`
        - From Features to Representations — `@ch04-features-to-representations`

## `p2--principles.qmd`
- Part II: Sequence Architectures — — *.unnumbered*

## `p2-ch05-representations.qmd`
- Tokens and Embeddings — `@ch05-representations`
    - One-Hot Encoding: The CNN Foundation — `@ch05-onehot`
    - *K*-mer Tokenization: The DNABERT Approach — `@ch05-kmer`
    - Byte Pair Encoding: Learning the Vocabulary — `@ch05-bpe`
    - Single-Nucleotide Tokenization: Maximum Resolution — `@ch05-single-nucleotide`
    - Biologically-Informed Tokenization — `@ch05-biological-tokenization`
    - From Tokens to Embeddings: Learning Representations — `@ch05-embeddings`
        - Position in Sequence — `@ch05-position`
    - Special Considerations for Biological Sequences — `@ch05-biological-special`
    - Tradeoffs and Practical Guidance — `@ch05-tradeoffs`
        - Resolution Versus Compression — `@ch05-resolution-compression`
        - Vocabulary Size and Model Capacity — `@ch05-vocabulary-capacity`
        - Computational Efficiency — `@ch05-computational-efficiency`
        - Variant Interpretation Requirements — `@ch05-variant-interpretation`
        - Practical Heuristics — `@ch05-heuristics`
    - Representation as Foundation — `@ch05-foundation`

## `p2-ch06-cnn.qmd`
- Convolutional Networks — `@ch06-cnn`
    - Convolutions as Sequence Pattern Detectors — `@ch06-convolutions`
    - *DeepSEA*: Regulatory Prediction from Sequence — `@ch06-deepsea`
        - Architecture and Training — `@ch06-deepsea-architecture`
        - Learned Representations and Biological Validation — `@ch06-deepsea-validation`
        - Variant Effect Prediction — `@ch06-deepsea-vep`
    - Cell-Type Specificity and Regulatory Grammar — `@ch06-basset`
    - *ExPecto*: From Chromatin to Expression — `@ch06-expecto`
        - Modular Architecture — `@ch06-expecto-architecture`
        - Expression Prediction and Variant Effects — `@ch06-expecto-validation`
    - *SpliceAI*: Clinical-Grade Splicing Prediction — `@ch06-spliceai`
        - Architecture: Depth and Dilation — `@ch06-spliceai-architecture`
        - Performance and Validation — `@ch06-spliceai-performance`
        - Clinical Impact — `@ch06-spliceai-clinical`
    - Receptive Field Ceiling — `@ch06-receptive-field`
    - Sequential Approaches and Their Costs — `@ch06-sequential`
        - Vanishing Gradient Problem — `@ch06-vanishing-gradient`
        - *DanQ*: Combining Convolutions and Recurrence — `@ch06-danq`
        - Sequential Bottleneck — `@ch06-sequential-bottleneck`
    - Specialization and Its Limits — `@ch06-specialization`

## `p2-ch07-attention.qmd`
- Transformers and Attention — `@ch07-attention`
    - Self-Attention Mechanism — `@ch07-self-attention`
        - Query, Key, and Value Vectors — `@ch07-qkv`
        - Multi-Head Attention — `@ch07-multihead`
    - Positional Encoding — `@ch07-positional-encoding`
        - Absolute Position Encodings — `@ch07-absolute-position`
        - Relative Position Encodings — `@ch07-relative-position`
        - Genomic Position Considerations — `@ch07-genomic-position`
    - Transformer Block — `@ch07-transformer-block`
        - Block Components — `@ch07-block-components`
        - Information Flow and Depth — `@ch07-depth`
    - Scaling to Genomic Sequences — `@ch07-scaling`
        - Quadratic Barrier — `@ch07-quadratic-barrier`
        - Parameter Considerations — `@ch07-parameters`
        - Context Length Strategies — `@ch07-context-strategies`
        - Memory and Precision — `@ch07-memory`
    - Architectural Variants for Genomics — `@ch07-variants`
        - Encoder-Only Transformers — `@ch07-encoder-only`
        - Decoder-Only Transformers — `@ch07-decoder-only`
        - Encoder-Decoder Transformers — `@ch07-encoder-decoder`
        - Hybrid CNN-Transformer Models — `@ch07-hybrid`
    - Training Dynamics — `@ch07-training`
        - Optimization — `@ch07-optimization`
        - Regularization — `@ch07-regularization`
        - Gradient Stability — `@ch07-gradients`
        - Distributed Training — `@ch07-distributed`
    - Limitations and Emerging Alternatives — `@ch07-limitations`
        - Quadratic Ceiling — `@ch07-quadratic-ceiling`
        - State Space Models — `@ch07-ssm`
        - Choosing Architectures — `@ch07-choosing`
    - Capacity Without Direction — `@ch07-conclusion`

## `p2-ch08-pretraining.qmd`
- Pretraining Strategies — `@ch08-pretraining`
    - Masked Language Modeling — `@ch08-mlm`
        - Masking Strategies and Their Implications — `@ch08-mlm-strategies`
        - What Masked Language Models Learn — `@ch08-mlm-learning`
    - Next-Token Prediction — `@ch08-autoregressive`
        - Genomic Applications — `@ch08-autoregressive-genomics`
    - MLM and Autoregressive Comparison — `@ch08-comparison`
        - Hybrid Architectures — `@ch08-hybrid`
    - Span Corruption and Denoising — `@ch08-denoising`
        - Corruption Beyond Masking — `@ch08-corruption`
        - Biologically Motivated Corruption — `@ch08-biological-corruption`
    - Contrastive Learning — `@ch08-contrastive`
        - Augmentation Design for Genomic Sequences — `@ch08-augmentation`
        - Cross-Species Contrastive Learning — `@ch08-cross-species`
    - Multi-Task Pretraining — `@ch08-multitask`
        - Task Selection and Architecture — `@ch08-task-selection`
        - Loss Weighting and Balancing — `@ch08-loss-weighting`
        - Large-Scale Multi-Task Examples — `@ch08-multitask-examples`
        - When Multi-Task Learning Fails — `@ch08-multitask-failure`
    - Staged Pretraining Strategies — `@ch08-staged`
        - Context Length Curricula — `@ch08-context-curriculum`
        - Domain-Adaptive Pretraining — `@ch08-domain-adaptive`
        - Continued Pretraining on Expanded Data — `@ch08-continued-pretraining`
        - Multi-Objective Schedules — `@ch08-multiobjective-schedule`
        - Data Complexity Curricula — `@ch08-data-complexity`
        - Practical Considerations — `@ch08-staged-practical`
    - Data Strategies for Pretraining — `@ch08-data`
        - Reference Genomes and Population Diversity — `@ch08-reference-genomes`
        - Repeat Handling — `@ch08-repeats`
        - Multi-Species and Augmentation Strategies — `@ch08-multispecies`
    - Optimization and Scaling — `@ch08-optimization`
        - Optimization Hyperparameters — `@ch08-hyperparameters`
        - Scaling Laws and Emergence — `@ch08-scaling`
    - Training Diagnostics — `@ch08-diagnostics`
        - Monitoring Loss and Gradients — `@ch08-monitoring`
        - Functional Probing — `@ch08-probing`
    - Strategy Selection — `@ch08-selection`
    - Pretraining in Practice: Case Studies — `@ch08-case-studies`
        - DNABERT — `@ch08-dnabert`
        - HyenaDNA — `@ch08-hyenadna`
        - Enformer — `@ch08-enformer`
        - ESM-2 — `@ch08-esm2`
    - Open Questions — `@ch08-open-questions`
    - From Sequence Statistics to Biological Knowledge — `@ch08-sequence-to-knowledge`

## `p2-ch09-transfer.qmd`
- Transfer Learning Foundations — `@ch09-transfer`
    - Source and Target Domains — `@ch09-source-target`
        - Gap Between Pretraining and Deployment — `@ch09-pretraining-deployment-gap`
        - Recognizing Transfer Outcomes — `@ch09-transfer-outcomes`
    - Factors Determining Transfer Success — `@ch09-transfer-factors`
        - Task Relatedness — `@ch09-task-relatedness`
        - Target Data Quantity — `@ch09-target-data-quantity`
        - Model Expressiveness — `@ch09-model-expressiveness`
        - Distribution Overlap — `@ch09-distribution-overlap`
        - Factor Interactions —
    - Feature Extraction and Representation Analysis — `@ch09-feature-extraction`
        - Linear Probing — `@ch09-linear-probing`
        - When Linear Probing Fails — `@ch09-linear-probing-limits`
        - Probing Representations — `@ch09-probing-representations`
        - What Probing Reveals About Pretrained Models — `@ch09-probing-results`
        - Probe-Guided Adaptation — `@ch09-probe-guided-adaptation`
    - Summary — `@ch09-summary`

## `p2-ch10-adaptation.qmd`
- Adaptation Strategies — `@ch10-adaptation`
    - Parameter-Efficient Fine-Tuning — `@ch10-peft`
        - Low-Rank Adaptation — `@ch10-lora`
        - Configuring Low-Rank Adaptation — `@ch10-lora-config`
    - Layer Selection for Embedding Extraction — `@ch10-layer-selection`
        - The Encoder Advantage —
        - The Decoder Dilemma —
        - Practical Consequences —
        - Layer Averaging and Weighted Combinations —
        - Systematic Layer Probing —
        - Implications for Model Selection —
        - Cross-Reference to Pretraining Objectives —
    - Full Fine-Tuning — `@ch10-full-finetuning`
        - Making Full Fine-Tuning Work — `@ch10-full-finetuning-practice`
        - The `[CLS]` Token and Sequence Aggregation — `@ch10-cls-token`
        - Mean Pooling and Alternatives —
        - Practical Considerations for Genomic Sequences —
    - Choosing an Adaptation Strategy — `@ch10-choosing-strategy`
    - Domain Shift and Cross-Context Transfer — `@ch10-domain-shift`
        - Types of Domain Shift in Genomics — `@ch10-domain-shift-types`
        - Detecting and Mitigating Shift — `@ch10-detecting-shift`
    - Minimal-Data and Emerging Transfer Paradigms — `@ch10-minimal-data`
        - Few-Shot Learning with Minimal Examples — `@ch10-few-shot`
        - Zero-Shot Transfer Without Task-Specific Data — `@ch10-zero-shot`
        - Emerging Approaches — `@ch10-emerging-approaches`
        - Toward Theoretical Foundations — `@ch10-theory`
    - Label and Class Imbalance — `@ch10-label-imbalance`
        - Manifestations During Transfer —
        - Mitigation Strategies —
        - Evaluation Under Imbalance —
        - Imbalance as Fundamental Constraint —
    - Diagnosing Transfer: Validation and Failure Modes — `@ch10-diagnosing-transfer`
        - Diagnosing Negative Transfer — `@ch10-negative-transfer`
        - Validation and Common Pitfalls — `@ch10-validation-pitfalls`
        - Sources of Spurious Success — `@ch10-spurious-success`
    - Case Studies in Transfer Learning — `@ch10-case-studies`
        - Successful Transfer: Alignment Between Pretraining and Task — `@ch10-case-success`
        - When Transfer Fails: Cross-Species Prediction — `@ch10-case-failure`
    - What Transfers, What Breaks — `@ch10-conclusion`

## `p2-ch11-benchmarks.qmd`
- Benchmarks and Evaluation — `@ch11-benchmarks`
    - Protein Language Model Benchmarks — `@ch11-protein-benchmarks`
        - TAPE: Tasks Assessing Protein Embeddings — `@ch11-tape`
        - FLIP: Function-Linked Protein Benchmark — `@ch11-flip`
        - ProteinGym: Comprehensive Variant Effect Evaluation — `@ch11-proteingym`
        - Structure Prediction Benchmarks — `@ch11-structure-benchmarks`
    - DNA and Regulatory Benchmarks — `@ch11-dna-benchmarks`
        - Classical Regulatory Prediction Tasks — `@ch11-classical-regulatory`
        - Quantitative Regulatory Prediction — `@ch11-quantitative-regulatory`
        - Genomic Benchmarks — `@ch11-genomic-benchmarks`
        - BEND: Benchmark for DNA Language Models — `@ch11-bend`
        - Long-Range Benchmarks — `@ch11-long-range`
        - Cross-Species Evaluation — `@ch11-cross-species`
    - Variant Effect Prediction Benchmarks — `@ch11-vep-benchmarks`
        - Clinical Variant Databases — `@ch11-clinical-databases`
        - CAGI: Critical Assessment of Genome Interpretation — `@ch11-cagi`
        - Deep Mutational Scanning Benchmarks — `@ch11-dms-benchmarks`
        - Regulatory and Non-Coding Variant Benchmarks — `@ch11-noncoding-benchmarks`
    - Trait and Population-Level Benchmarks — `@ch11-trait-benchmarks`
        - Polygenic Score Evaluation — `@ch11-pgs-evaluation`
        - TraitGym — `@ch11-traitgym`
        - EmbedGEM Framework — `@ch11-embedgem`
    - Benchmark Construction and Hidden Assumptions — `@ch11-benchmark-construction`
        - Data Sources and Label Provenance — `@ch11-label-provenance`
        - Splitting Strategies and Leakage — `@ch11-splitting`
        - Metric Selection and Aggregation — `@ch11-metrics`
        - Goodhart's Law and Benchmark Gaming — `@ch11-goodhart`
    - Benchmark Saturation and Staleness — `@ch11-saturation-staleness`
        - Saturation: When Benchmarks Stop Discriminating — `@ch11-saturation`
        - Staleness: When Benchmarks Diverge from Practice — `@ch11-staleness`
        - Leakage from Scale — `@ch11-leakage-scale`
    - Benchmark-Deployment Gap — `@ch11-deployment-gap`
        - Distribution Shift — `@ch11-distribution-shift`
        - Calibration Requirements — `@ch11-calibration-requirements`
        - Metric Mismatch — `@ch11-metric-mismatch`
        - Practical Constraints — `@ch11-practical-constraints`
    - Systematic Gaps in Current Benchmarks — `@ch11-systematic-gaps`
    - The Proxy Problem — `@ch11-proxy-problem`
    - Evaluation Methodology — `@ch11-evaluation-methodology`
- Evaluation Principles — `@ch11-eval`
    - Why Random Splits Fail — `@ch11-random-splits-fail`
    - Homology-Aware Splitting — `@ch11-homology-aware-splitting`
        - Clustering Tools and Workflows — `@ch11-clustering-tools`
        - Practical Considerations — `@ch11-homology-practical`
    - Splitting by Biological Axis — `@ch11-splitting-biological-axis`
        - Splitting by Individual — `@ch11-splitting-individual`
        - Splitting by Genomic Region — `@ch11-splitting-genomic-region`
        - Splitting by Gene or Protein Family — `@ch11-splitting-gene-family`
        - Splitting by Experimental Context — `@ch11-splitting-experimental-context`
        - Splitting by Ancestry — `@ch11-splitting-ancestry`
        - Splitting by Time — `@ch11-splitting-time`
    - Leakage Taxonomy and Detection — `@ch11-leakage-detection`
        - Label Leakage — `@ch11-label-leakage`
        - Feature Leakage — `@ch11-feature-leakage`
        - Temporal Leakage — `@ch11-temporal-leakage`
        - Benchmark Leakage — `@ch11-benchmark-leakage`
        - Detecting Leakage — `@ch11-detecting-leakage`
    - Metrics for Genomic Tasks — `@ch11-metrics-genomic-tasks`
        - Discrimination Metrics — `@ch11-discrimination-metrics`
        - Regression and Correlation Metrics — `@ch11-regression-correlation-metrics`
        - Ranking and Prioritization Metrics — `@ch11-ranking-prioritization-metrics`
        - Clinical Utility Metrics — `@ch11-clinical-utility-metrics`
    - Baseline Selection — `@ch11-baseline-selection`
        - Strong Baselines, Not Straw Men — `@ch11-strong-baselines`
        - Historical Baselines and Progress Tracking — `@ch11-historical-baselines`
        - Non-Deep-Learning Baselines — `@ch11-non-dl-baselines`
    - Ablation Studies — `@ch11-ablation-studies`
        - Component Isolation — `@ch11-component-isolation`
        - Hyperparameter Sensitivity — `@ch11-hyperparameter-sensitivity`
        - Architecture Search Confounds — `@ch11-architecture-search-confounds`
        - Reporting Standards — `@ch11-reporting-standards`
    - Statistical Rigor — `@ch11-statistical-rigor`
        - Significance Testing — `@ch11-significance-testing`
        - Effect Sizes — `@ch11-effect-sizes`
        - Confidence Intervals on Metrics — `@ch11-confidence-intervals`
        - Variance Across Random Seeds — `@ch11-variance-random-seeds`
    - Evaluating Foundation Models — `@ch11-evaluating-fm`
        - Zero-Shot Evaluation — `@ch11-zero-shot-eval`
        - Linear Probing — `@ch11-linear-probing`
        - Fine-Tuning Evaluation — `@ch11-fine-tuning-eval`
        - Transfer Across Tasks — `@ch11-transfer-tasks`
    - Calibration Essentials — `@ch11-calibration`
        - Assessing Calibration — `@ch11-assessing-calibration`
        - Recalibration Methods — `@ch11-recalibration-methods`
        - Calibration in Model Comparison — `@ch11-calibration-comparison`
    - Putting It All Together — `@ch11-putting-together`
    - The Question Behind the Metric — `@ch11-question-behind-metric`

## `p2-ch12-confounding.qmd`
- Confounding and Data Leakage — `@ch12-confounding`
    - Confounding, Bias, and Leakage — `@ch12-terminology`
    - Sources of Confounding in Genomic Data — `@ch12-sources`
        - Population Structure and Relatedness — `@ch12-ancestry-confounding`
        - Technical Batch Effects — `@ch12-batch-effects`
        - Institutional and Recruitment Confounding — `@ch12-institutional-confounding`
        - Label Generation Bias — `@ch12-label-bias`
        - Temporal Drift — `@ch12-temporal-drift`
        - Resource Overlap and Indirect Leakage — `@ch12-resource-overlap`
    - Population Structure as a Shortcut — `@ch12-population-shortcut`
    - Technical Artifacts as Biological Signal — `@ch12-technical-artifacts`
    - Label Bias and Circularity — `@ch12-label-circularity`
    - Data Splitting — `@ch12-data-splitting`
        - Random Individual-Level Splits — `@ch12-random-splits`
        - Family-Aware Splits — `@ch12-family-splits`
        - Locus-Level Splits — `@ch12-locus-splits`
        - Region and Chromosome Splits — `@ch12-region-splits`
        - Cohort and Site Splits — `@ch12-cohort-splits`
        - Temporal Splits — `@ch12-temporal-splits`
        - Indirect Leakage Across Resources — `@ch12-indirect-leakage`
    - Data Leakage as Confounding — `@ch12-leakage-confounding`
        - Causal Structure of Leakage — `@ch12-leakage-causal`
        - Compounding Effects — `@ch12-compounding`
        - Implications for Confounding Analysis — `@ch12-leakage-implications`
    - Detecting Confounding — `@ch12-detection`
        - Confounder-Only Baselines — `@ch12-confounder-baselines`
        - Stratified Performance Analysis — `@ch12-stratified-performance`
        - Residual Confounder Associations — `@ch12-residual-associations`
        - Split Sensitivity Analysis — `@ch12-split-sensitivity`
        - Negative Control Outcomes — `@ch12-negative-controls`
    - Mitigation Strategies — `@ch12-mitigation`
        - Study Design and Cohort Construction — `@ch12-study-design`
        - Covariate Adjustment — `@ch12-covariate-adjustment`
        - Domain Adaptation and Invariance Learning — `@ch12-domain-adaptation`
        - Data Curation and Benchmark Design — `@ch12-benchmark-design`
        - Causal Inference Approaches — `@ch12-causal-inference`
    - Fairness and External Validity — `@ch12-fairness`
    - A Practical Checklist — `@ch12-checklist`
    - Rigor as Response — `@ch12-rigor`

## `p3--architectures.qmd`
- Part III: Foundation Model Families — — *.unnumbered*

## `p3-ch13-fm-principles.qmd`
- Foundation Model Paradigm — `@ch13-fm-principles`
    - From Task-Specific Models to Foundation Models — `@ch13-task-specific`
    - Defining Genomic Foundation Models — `@ch13-defining`
        - Essential Properties — `@ch13-essential-properties`
        - What does not Count — `@ch13-what-doesnt-count`
        - Limitations of the Foundation Model Concept — `@ch13-concept-limitations`
    - Scaling Laws and Compute-Optimal Training — `@ch13-scaling`
        - Chinchilla Framework and Genomic Constraints — `@ch13-scaling-framework`
        - Empirical Scaling in Genomic Models — `@ch13-empirical-scaling`
        - Emergent Capabilities — `@ch13-emergence`
    - A Taxonomy of Genomic Foundation Models — `@ch13-taxonomy`
        - DNA Language Models — `@ch13-dna-lm`
        - Sequence-to-Function Foundation Models — `@ch13-seq-to-func`
        - Variant Effect Prediction Models — `@ch13-vep-models`
        - Multi-Omic Foundation Models — `@ch13-multi-omic`
    - Design Dimensions — `@ch13-design-dimensions`
        - Data Composition — `@ch13-data-composition`
        - Architecture Choices — `@ch13-architecture`
        - Context Length — `@ch13-context-length`
        - Tokenization — `@ch13-tokenization`
    - Build Versus Use Decisions — `@ch13-build-vs-use`
        - When to Use Existing Models — `@ch13-use-existing`
        - When to Adapt Existing Models — `@ch13-adapt-existing`
        - When to Train from Scratch — `@ch13-train-scratch`
        - Cost-Benefit Analysis — `@ch13-cost-benefit`
    - Evaluation Principles — `@ch13-evaluation`
        - Multi-Task Assessment — `@ch13-multi-task`
        - Transfer Versus Pretraining Performance — `@ch13-transfer-eval`
    - Foundation Model Ecosystem — `@ch13-ecosystem`
        - Model Distribution — `@ch13-distribution`
        - Documentation Requirements — `@ch13-documentation`
        - Industry and Academic Contributions — `@ch13-contributions`
    - Open Questions — `@ch13-open-questions`
    - Convergence Without Consolidation — `@ch13-convergence`

## `p3-ch14-dna-lm.qmd`
- DNA Language Models — `@ch14-dna-lm`
    - From Task-Specific CNNs to General-Purpose Language Models — `@ch14-task-specific-to-general`
    - *DNABERT*: The First DNA Language Model — `@ch14-dnabert`
    - *Nucleotide Transformer*: Scaling Data and Model Diversity — `@ch14-nucleotide-transformer`
    - *GPN*: Cross-Species Pretraining for Variant Effect Prediction — `@ch14-gpn`
    - Long-Context Revolution — `@ch14-long-context`
        - *HyenaDNA*: Megabase Context via Implicit Convolutions — `@ch14-hyenadna`
        - *Caduceus*: Bidirectional Processing with Reverse-Complement Equivariance — `@ch14-caduceus`
        - *Evo 2*: Genome-Scale Modeling Across the Tree of Life — `@ch14-evo2`
    - Training Data and What Models Learn — `@ch14-training-data`
        - Training Corpus Composition — `@ch14-corpus-composition`
        - Probing What Models Learn — `@ch14-probing`
        - What Models Do Not Learn — `@ch14-limitations-learned`
    - Benchmark Performance and Evaluation — `@ch14-benchmarks`
        - Major Benchmark Suites — `@ch14-benchmark-suites`
        - Benchmark Limitations — `@ch14-benchmark-limitations`
    - Annotation-Aware Extensions — `@ch14-annotation-aware`
    - Using DNA Language Models in Practice — `@ch14-practical-use`
        - Embeddings as Universal Features — `@ch14-embeddings`
        - Fine-Tuning and Adaptation — `@ch14-fine-tuning`
        - Zero-Shot and Few-Shot Scoring — `@ch14-zero-shot`
    - Limitations and Open Challenges — `@ch14-open-challenges`
    - Representations Without Predictions — `@ch14-soft-landing`

## `p3-ch15-protein-lm.qmd`
- Protein Language Models — `@ch15-protein-lm`
    - ESM Model Family — `@ch15-esm-family`
        - ESM-1b: Establishing the Paradigm — `@ch15-esm1b`
        - Emergent Biological Knowledge — `@ch15-emergent-knowledge`
        - ESM-2: Scaling Up — `@ch15-esm2`
    - Alternative Architectures — `@ch15-alternative-architectures`
    - Attention and Evolutionary Coupling — `@ch15-attention-coupling`
    - ESMFold: Structure from Sequence — `@ch15-esmfold`
        - Alignment-Free Prediction — `@ch15-alignment-free`
        - What ESMFold Reveals About PLMs — `@ch15-esmfold-implications`
    - Function Prediction — `@ch15-function-prediction`
    - Variant Effect Prediction — `@ch15-variant-effects`
    - Integration with Structure Prediction — `@ch15-structure-integration`
    - Limitations — `@ch15-limitations`
        - Orphan and Dark Proteins — `@ch15-orphan-proteins`
        - Novel Folds — `@ch15-novel-folds`
        - Conformational Flexibility — `@ch15-conformational-flexibility`
        - Epistasis — `@ch15-epistasis`
        - Interpretability — `@ch15-interpretability`
    - Lessons for Genomic Foundation Models — `@ch15-lessons`
        - Self-Supervised Biological Knowledge — `@ch15-self-supervised`
        - Scaling Benefits — `@ch15-scaling`
        - Effective Transfer Learning — `@ch15-transfer`
        - Architecture-Sequence Matching — `@ch15-architecture-matching`
        - Integration Benefits — `@ch15-integration`
    - Paradigm That Generalized — `@ch15-conclusion`

## `p3-ch16-regulatory.qmd`
- Regulatory Models — `@ch16-regulatory`
    - Long-Range Regulation Problem — `@ch16-long-range`
    - *Enformer*: Attention Meets Regulatory Genomics — `@ch16-enformer`
        - Architecture — `@ch16-enformer-architecture`
        - Training Data and Cross-Species Learning — `@ch16-enformer-training`
        - Variant Effect Prediction — `@ch16-enformer-vep`
    - *Borzoi*: From Chromatin to Transcriptome — `@ch16-borzoi`
        - Beyond Transcription Initiation — `@ch16-borzoi-transcription`
        - Predicting Coverage at Nucleotide Resolution — `@ch16-borzoi-coverage`
        - Applications Beyond Expression Level — `@ch16-borzoi-applications`
    - *Sei*: A Regulatory Vocabulary from Sequence — `@ch16-sei`
        - Discrete Regulatory States — `@ch16-sei-states`
        - Complementary to Track Prediction — `@ch16-sei-complementary`
    - *AlphaGenome*: Unifying Modalities at Megabase Scale — `@ch16-alphagenome`
        - From 200kb to One Megabase — `@ch16-alphagenome-scale`
        - Closed Weights, Open Questions — `@ch16-alphagenome-access`
    - What Hybrid Architectures Accomplish — `@ch16-accomplishments`
        - Spanning Enhancer-Promoter Distances — `@ch16-spanning`
        - Multi-Task Regularization — `@ch16-multitask`
        - Cross-Species Constraints — `@ch16-cross-species`
        - Unified Variant Effect Prediction — `@ch16-unified-vep`
    - Limitations and Open Challenges — `@ch16-limitations`
        - Training Data Constraints — `@ch16-training-bias`
        - Finite Context — `@ch16-finite-context`
        - Missing Three-Dimensional Context — `@ch16-missing-3d`
        - Correlation Versus Causation — `@ch16-correlation`
        - Interpretability Challenges — `@ch16-interpretability`
    - Relationship to Foundation Models — `@ch16-foundation-models`
    - Prediction Without Explanation — `@ch16-prediction-explanation`

## `p3-ch17-vep-fm.qmd`
- Variant Effect Prediction — `@ch17-vep-fm`
    - Foundation Model Paradigm for Variant Interpretation — `@ch17-fm-paradigm`
        - Zero-Shot and Supervised Approaches — `@ch17-zeroshot-supervised`
    - Protein-Based Variant Effect Prediction — `@ch17-protein-vep`
        - Zero-Shot Scoring with Protein Language Models — `@ch17-zeroshot-plm`
        - Alignment-Based Models: EVE and popEVE — `@ch17-alignment-models`
        - AlphaMissense: Structure-Informed Pathogenicity Prediction — `@ch17-alphamissense`
    - DNA-Based Variant Effect Prediction — `@ch17-dna-vep`
        - Splice Variant Prediction with SpliceAI — `@ch17-spliceai`
        - Regulatory Variant Prediction with Enformer — `@ch17-enformer-vep`
        - DNA Language Models: GPN-MSA and Evo 2 — `@ch17-dna-lm-vep`
        - AlphaGenome: Unified Multi-Omic Variant Effect Prediction — `@ch17-alphagenome`
    - Combining Evidence Across Modalities — `@ch17-combining-evidence`
        - Integration Strategies — `@ch17-integration-strategies`
        - Avoiding Double-Counting — `@ch17-double-counting`
        - Practical Workflow Design — `@ch17-workflow-design`
    - Calibration and Clinical Categories — `@ch17-calibration`
        - Assessing Calibration — `@ch17-assessing-calibration`
        - Calibration Methods for Variant Effect Prediction — `@ch17-calibration-methods`
        - Mapping to ACMG Categories — `@ch17-acmg-mapping`
        - The Challenge of Uncertain Significance — `@ch17-vus-challenge`
    - Uncertainty Quantification — `@ch17-uncertainty`
        - Sources of Uncertainty — `@ch17-uncertainty-sources`
        - Uncertainty Estimation Methods — `@ch17-uncertainty-methods`
        - Out-of-Distribution Detection — `@ch17-ood-detection`
    - What Foundation Models Add — `@ch17-fm-gains`
        - Improved Discrimination — `@ch17-improved-discrimination`
        - Extended Coverage — `@ch17-extended-coverage`
        - Mechanistic Interpretability — `@ch17-mechanistic-interpretability`
        - Persistent Limitations — `@ch17-persistent-limitations`
    - Clinical Integration Considerations — `@ch17-clinical-integration`
        - Laboratory Validation — `@ch17-lab-validation`
        - Workflow Integration — `@ch17-workflow-integration`
        - Communication to Clinicians — `@ch17-clinical-communication`
    - Open Challenges — `@ch17-open-challenges`
        - Complex Variant Types — `@ch17-complex-variants`
        - Combinatorial Effects — `@ch17-combinatorial`
        - Phenotype Specificity — `@ch17-phenotype-specificity`
        - Temporal and Environmental Context — `@ch17-temporal-context`
        - Equity and Access — `@ch17-equity`
    - Tools for Interpretation, Not Oracles — `@ch17-conclusion`

## `p4--multi-modal.qmd`
- Part IV: Systems and Scale — — *.unnumbered*

## `p4-ch18-rna.qmd`
- RNA Structure and Function — `@ch18-rna`
    - RNA as Molecule Versus Transcriptome Readout — `@ch18-perspectives`
    - Why Secondary Structure Creates a Distinct Modeling Challenge — `@ch18-structure-challenge`
        - Flat Energy Landscape Problem — `@ch18-energy-landscape`
        - Base Pairing and Long-Range Dependencies — `@ch18-base-pairing`
        - Pseudoknots and Tertiary Complexity — `@ch18-pseudoknots`
    - Classical Approaches to Structure Prediction — `@ch18-classical`
        - Thermodynamic Folding Models — `@ch18-thermodynamic`
        - Comparative and Covariation Methods — `@ch18-comparative`
    - Deep Learning for Secondary Structure Prediction — `@ch18-dl-structure`
        - From Thermodynamics to Learned Patterns — `@ch18-learned-patterns`
        - Structure Probing as Supervision — `@ch18-structure-probing`
    - RNA Foundation Models — `@ch18-foundation`
        - Scale Gap with Protein Language Models — `@ch18-scale-gap`
        - Architectures and Objectives — `@ch18-architectures`
        - Downstream Applications — `@ch18-downstream`
    - Codon-Level Models for Coding RNA — `@ch18-codon`
        - Beyond Nucleotide Tokenization — `@ch18-codon-tokenization`
        - What Codon Models Add — `@ch18-codon-advantages`
    - UTR Models and Translation Regulation — `@ch18-utr`
        - Why UTRs Dominate Expression Control — `@ch18-utr-control`
        - Sequence-to-Expression Models — `@ch18-expression-models`
        - Integration with mRNA Design — `@ch18-utr-design`
    - mRNA Design and Optimization — `@ch18-mrna-design`
        - Design Objectives and Trade-offs — `@ch18-design-objectives`
        - Lessons from COVID-19 Vaccines — `@ch18-covid-vaccines`
        - Model-Based Design Strategies — `@ch18-model-design`
    - Noncoding RNA Classification and Function — `@ch18-ncrna`
        - Diversity of Noncoding RNA — `@ch18-ncrna-diversity`
        - From Handcrafted Features to Learned Representations — `@ch18-ncrna-features`
    - miRNA Target Prediction — `@ch18-mirna`
    - Splicing and Transcript Processing Models — `@ch18-splicing`
        - Beyond SpliceAI — `@ch18-beyond-spliceai`
    - Limitations and Open Challenges — `@ch18-limitations`
        - Sparse Structural Data — `@ch18-sparse-data`
        - Functional Annotation Gaps — `@ch18-annotation-gaps`
        - Maturity Gap — `@ch18-maturity-gap`
    - Bridge Between Sequence and Cell — `@ch18-bridge`

## `p4-ch19-single-cell.qmd`
- Single-Cell Models — `@ch19-single-cell`
    - Single-Cell Data Landscape — `@ch19-data`
        - From Bulk to Single-Cell Resolution — `@ch19-bulk-to-sc`
        - Technical Challenges and Data Characteristics — `@ch19-technical`
    - Cellular Language Models — `@ch19-clm`
        - *Geneformer*: Learning Network Biology — `@ch19-geneformer`
        - *scGPT*: Generative Pretraining for Single-Cell Analysis — `@ch19-scgpt`
        - *scFoundation* and Scaling Single-Cell Models — `@ch19-scfoundation`
        - *TranscriptFormer*: Cross-Species Cellular Models — `@ch19-transcriptformer`
    - Perturbation Response Prediction — `@ch19-perturbation`
        - *In Silico* Experiment Promise — `@ch19-in-silico`
        - Perturb-seq and Foundation Model Training — `@ch19-perturb-seq`
        - Limitations of Current Approaches — `@ch19-perturbation-limits`
    - Epigenomic Foundation Models — `@ch19-epigenomic`
        - DNA Methylation and *CpGPT* — `@ch19-methylation`
        - Chromatin Accessibility Models — `@ch19-accessibility`
    - Cross-Modality Integration — `@ch19-integration`
        - Unpaired Integration Challenge — `@ch19-unpaired`
        - *GLUE*: Graph-Linked Unified Embedding — `@ch19-glue`
        - Applications of Cross-Modal Integration — `@ch19-cross-modal-apps`
    - Practical Challenges and Limitations — `@ch19-limitations`
        - Batch Effects and Technical Artifacts — `@ch19-batch-effects`
        - Cell Type Imbalance — `@ch19-imbalance`
        - Evaluation Complexity — `@ch19-evaluation`
        - Causality and Mechanism — `@ch19-causality`
    - From Sequence to State — `@ch19-conclusion`

## `p4-ch20-3d-genome.qmd`
- 3D Genome Organization — `@ch20-3d-genome`
    - Chromatin Organization Hierarchy — `@ch20-chromatin-hierarchy`
        - Chromosome Territories and Compartments — `@ch20-territories-compartments`
        - Topologically Associating Domains — `@ch20-tads`
        - Loop Extrusion Mechanism — `@ch20-loop-extrusion`
        - Fine-Scale Chromatin Loops — `@ch20-fine-scale-loops`
    - Measuring the 3D Genome — `@ch20-3d-measurement`
        - Hi-C and Contact Matrices — `@ch20-hic-matrices`
        - Resolution and Data Resources — `@ch20-3d-data-resources`
    - Predicting 3D Structure from Sequence — `@ch20-3d-prediction`
        - *Akita* and Dilated Convolutions — `@ch20-akita`
        - *Orca* and Multiscale Prediction — `@ch20-orca`
        - *C.Origami* and Cross-Cell-Type Transfer — `@ch20-c-origami`
        - Learned Sequence Determinants — `@ch20-3d-interpretability`
    - 3D Structure and Gene Regulation — `@ch20-3d-regulation`
        - Beyond One-Dimensional Models — `@ch20-beyond-1d`
        - Structural Variant Interpretation — `@ch20-sv-interpretation`
        - Causality and Permissive Architecture — `@ch20-3d-causality`
    - Spatial Transcriptomics — `@ch20-spatial-transcriptomics`
        - Measurement Technologies — `@ch20-spatial-technologies`
        - Computational Challenges — `@ch20-spatial-computation`
        - Spatial Foundation Models — `@ch20-spatial-models`
    - Limitations and Open Questions — `@ch20-3d-limitations`
    - Structure as Context, Not Cause — `@ch20-structure-context`

## `p4-ch21-networks.qmd`
- Graph and Network Models — `@ch21-networks`
    - Biological Networks and Data Resources — `@ch21-biological-networks`
        - Landscape of Biological Graphs — `@ch21-landscape`
        - Biases and Limitations — `@ch21-network-biases`
    - Graph Neural Network Fundamentals — `@ch21-gnn-fundamentals`
        - Message Passing Principles — `@ch21-message-passing`
        - Canonical Architectures — `@ch21-canonical-architectures`
    - Foundation Model Embeddings as Node Features — `@ch21-fm-embeddings`
        - Integration Principle — `@ch21-integration-principle`
        - Practical Integration Patterns — `@ch21-practical-patterns`
        - Evidence for the Integration Benefit — `@ch21-integration-evidence`
    - Applications — `@ch21-applications`
        - Disease Gene Prioritization — `@ch21-disease-gene`
        - Drug-Target Interaction Prediction — `@ch21-drug-target`
        - Knowledge Graph Reasoning and Drug Repurposing — `@ch21-kg-reasoning`
        - Pathway and Module Analysis — `@ch21-pathway-analysis`
        - Cell Type and State Annotation — `@ch21-cell-annotation`
    - Practical Considerations — `@ch21-practical`
        - Graph Construction Quality — `@ch21-graph-construction`
        - Scalability and Mini-Batching — `@ch21-scalability`
        - Robustness to Noise and Missingness — `@ch21-robustness`
        - Interpretation and Validation — `@ch21-interpretation`
    - Limitations and Open Challenges — `@ch21-limitations`
        - Study Bias Problem — `@ch21-study-bias`
        - Causality Versus Association — `@ch21-causality`
        - Negative Data and Class Imbalance — `@ch21-negative-data`
        - Distribution Shift — `@ch21-distribution-shift`
    - Sequence Encodes, Structure Connects — `@ch21-conclusion`

## `p4-ch22-multi-omics.qmd`
- Multi-Omics Integration — `@ch22-multi-omics`
    - Limits of Single-Modality Models — `@ch22-limits`
    - Integration Strategies and Their Tradeoffs — `@ch22-strategies`
        - Early Fusion — `@ch22-early-fusion`
        - Late Fusion — `@ch22-late-fusion`
        - Intermediate Fusion — `@ch22-intermediate-fusion`
    - Multi-Omics Foundation Models — `@ch22-foundation-models`
        - Factor-Based Integration — `@ch22-factor-integration`
        - Deep Generative Multi-Omics Models — `@ch22-deep-generative`
        - Contrastive Multi-Modal Learning — `@ch22-contrastive`
    - Clinical Integration: EHR, Imaging, and Molecular Data — `@ch22-clinical-integration`
        - Electronic Health Records as a Modality — `@ch22-ehr`
        - Imaging Integration — `@ch22-imaging`
        - Multi-Modal Clinical Prediction Models — `@ch22-multimodal-clinical`
    - Systems View: From Variant to Phenotype — `@ch22-systems-view`
        - Information Cascade — `@ch22-information-cascade`
        - Bottleneck Modalities — `@ch22-bottleneck`
        - Causal vs. Correlational Integration — `@ch22-causal-correlational`
    - Handling Missing Modalities — `@ch22-missing-modalities`
        - Training with Incomplete Data — `@ch22-incomplete-training`
        - Cross-Modal Imputation — `@ch22-imputation`
        - Zero-Shot Cross-Modal Transfer — `@ch22-zero-shot`
    - Practical Challenges — `@ch22-practical-challenges`
        - Batch Effects Across Modalities — `@ch22-batch-effects`
        - Sample Size and Power — `@ch22-sample-size`
        - Interpretability Across Modalities — `@ch22-interpretability`
        - Evaluation Complexity — `@ch22-evaluation`
    - Integration as Means, Not End — `@ch22-conclusion`

## `p5--responsible-deployment.qmd`
- Part V: Evaluation and Trust — — *.unnumbered*

## `p5-ch23-uncertainty.qmd`
- Uncertainty Quantification — `@ch23-uncertainty`
    - Types of Uncertainty in Genomic Prediction — `@ch23-types`
        - Why Uncertainty Matters — `@ch23-why-uncertainty`
        - Epistemic Uncertainty — `@ch23-epistemic`
        - Aleatoric Uncertainty — `@ch23-aleatoric`
        - Decomposing Total Uncertainty — `@ch23-decomposition`
    - Calibration and Confidence Interpretation — `@ch23-calibration`
        - The Calibration Problem — `@ch23-calibration-problem`
        - Measuring Calibration — `@ch23-measuring-calibration`
        - Why Foundation Models Are Often Miscalibrated — `@ch23-fm-miscalibration`
        - Calibration Across Subgroups — `@ch23-subgroup-calibration`
    - Post-Hoc Calibration Methods — `@ch23-post-hoc-calibration`
        - Temperature Scaling — `@ch23-temperature-scaling`
        - Platt Scaling — `@ch23-platt-scaling`
        - Isotonic Regression — `@ch23-isotonic-regression`
        - Calibrating Foundation Model Outputs — `@ch23-calibrating-fm`
    - Uncertainty Quantification Methods for Foundation Models — `@ch23-uq-methods`
        - Deep Ensembles — `@ch23-deep-ensembles`
        - Monte Carlo Dropout — `@ch23-mc-dropout`
        - Heteroscedastic Models — `@ch23-heteroscedastic`
        - Evidential Deep Learning — `@ch23-evidential`
        - Selecting Uncertainty Quantification Methods — `@ch23-selecting-uq`
    - Conformal Prediction: Distribution-Free Guarantees — `@ch23-conformal`
        - Split Conformal Prediction — `@ch23-split-conformal`
        - Conformal Prediction for Variant Classification — `@ch23-conformal-variant`
        - Limitations and Practical Considerations — `@ch23-conformal-limitations`
        - Integration with Clinical Workflows — `@ch23-conformal-clinical`
    - Out-of-Distribution Detection — `@ch23-ood-detection`
        - Out-of-Distribution Problem — `@ch23-ood-problem`
        - Likelihood-Based Detection and Its Failures — `@ch23-likelihood-ood`
        - Embedding-Based Detection — `@ch23-embedding-ood`
        - Practical OOD Detection for Genomic Applications — `@ch23-practical-ood`
    - Selective Prediction and Abstention — `@ch23-selective-prediction`
        - When to Abstain — `@ch23-when-abstain`
        - Selective Prediction Methods — `@ch23-selective-methods`
        - Evaluating Selective Prediction — `@ch23-selective-eval`
    - Uncertainty for Specific Genomic Tasks — `@ch23-genomic-uq`
        - Variant Effect Prediction Uncertainty — `@ch23-vep-uncertainty`
        - Regulatory Variant Uncertainty — `@ch23-regulatory-uncertainty`
        - Uncertainty Across Populations — `@ch23-population-uncertainty`
    - Communicating Uncertainty to End Users — `@ch23-communication`
        - Communication Challenge — `@ch23-communication-challenge`
        - Categorical Reporting — `@ch23-categorical-reporting`
        - Visual Communication — `@ch23-visual-communication`
        - Decision-Theoretic Framing — `@ch23-decision-framing`
    - Necessary but Insufficient — `@ch23-conclusion`

## `p5-ch24-interpretability.qmd`
- Interpretability — `@ch24-interpretability`
    - Attribution Methods and Input Importance — `@ch24-attribution`
        - *In Silico* Mutagenesis — `@ch24-ism`
        - Gradient-Based Attribution — `@ch24-gradient`
        - Reconciling Attribution Methods — `@ch24-reconciling`
    - Interpreting Convolutional Filters — `@ch24-cnn-filters`
        - From Filters to Position Weight Matrices — `@ch24-filter-pwm`
        - Deeper Layers and Combinatorial Patterns — `@ch24-deeper-layers`
    - Motif Discovery from Attributions — `@ch24-motif-discovery`
    - Probing Learned Representations — `@ch24-probing`
        - Probing Methodology — `@ch24-probing-methods`
        - Limitations of Probing — `@ch24-probing-limits`
    - Attention Patterns in Transformer Models — `@ch24-attention`
        - What Attention Patterns Reveal — `@ch24-attention-patterns`
        - Why Attention Weights Mislead — `@ch24-attention-caution`
    - Regulatory Vocabularies and Global Interpretability — `@ch24-global`
        - Sequence Classes from *Sei* — `@ch24-sei`
        - Embedding Geometry and Regulatory Programs — `@ch24-embedding-geometry`
    - Mechanistic Interpretability — `@ch24-mechanistic`
        - Circuits and Features — `@ch24-circuits`
        - Applications to Genomic Models — `@ch24-mechanistic-genomics`
    - Validation: From Explanations to Experiments — `@ch24-validation`
        - Faithfulness Testing — `@ch24-faithfulness`
        - Experimental Validation — `@ch24-experimental`
    - Interpretability in Clinical Variant Assessment — `@ch24-clinical`
    - Practical Approaches for Foundation Model Analysis — `@ch24-practical`
    - Plausibility Is Not Faithfulness — `@ch24-conclusion`

## `p5-ch25-causal.qmd`
- Causal Inference with Foundation Models — `@ch25-causal`
    - Prediction vs. Causation — `@ch25-prediction-vs-causation`
        - The Ladder of Causation — `@ch25-ladder`
        - Why Predictive Accuracy ≠ Causal Understanding — `@ch25-prediction-not-causation`
        - The Clinical Stakes — `@ch25-clinical-stakes`
    - Causal Methods in Genomics — `@ch25-causal-methods`
        - Mendelian Randomization — `@ch25-mendelian-randomization`
        - Fine-Mapping for Causal Variants — `@ch25-fine-mapping`
        - From GWAS to Causal Genes — `@ch25-gwas-to-genes`
    - Foundation Models and Causality — `@ch25-fm-causality`
        - Can Foundation Models Learn Causal Structure? — `@ch25-fm-causal-structure`
        - In-Silico Perturbation Prediction — `@ch25-in-silico-perturbation`
        - Counterfactual Reasoning Limitations — `@ch25-counterfactual-limits`
    - Intervention Prediction — `@ch25-intervention-prediction`
        - CRISPR Screen Analysis with Foundation Models — `@ch25-crispr-screens`
        - Drug Response Prediction — `@ch25-drug-response`
        - Closed-Loop Experimental Validation — `@ch25-closed-loop`
    - Causal Discovery — `@ch25-causal-discovery`
        - Learning Regulatory Networks — `@ch25-regulatory-networks`
        - Temporal Causality — `@ch25-temporal-causality`
        - Multi-Omics Causal Structure — `@ch25-multi-omics-causal`
    - Clinical Implications — `@ch25-clinical-implications`
        - Drug Target Validation Evidence Hierarchy — `@ch25-target-validation`
        - Regulatory Requirements for Causal Claims — `@ch25-regulatory-requirements`
    - Looking Forward — `@ch25-conclusion`

## `p5-ch26-regulatory.qmd`
- Regulatory and Governance — `@ch26-regulatory`
    - Regulatory Frameworks for Genomic AI — `@ch26-regulatory`
        - Software as Medical Device Paradigm — `@ch26-samd`
        - European and Global Regulatory Landscapes — `@ch26-global-regulation`
        - Validation Requirements for Clinical Genomic AI — `@ch26-validation`
    - Data Governance and Consent — `@ch26-governance`
        - Consent Problem at Scale — `@ch26-consent`
        - Biobank Governance Models — `@ch26-biobanks`
        - Secondary Use and Data Futures — `@ch26-secondary-use`
    - Privacy and Genomic Data — `@ch26-privacy`
        - Re-identification Challenge — `@ch26-reidentification`
        - Family and Relational Privacy — `@ch26-family-privacy`
    - Intellectual Property and Ownership — `@ch26-ip`
        - Genomic Data Ownership — `@ch26-data-ownership`
        - Model Weights as Assets — `@ch26-model-weights`
        - Prediction Ownership and Liability — `@ch26-liability`
    - Responsible Development Practices — `@ch26-responsible`
        - Transparency and Documentation — `@ch26-transparency`
        - Fairness and Performance Equity — `@ch26-fairness`
        - Human Oversight and Decision Support — `@ch26-oversight`
    - Dual Use and Biosecurity — `@ch26-biosecurity`
        - Generative Models and Pathogen Enhancement — `@ch26-pathogen`
        - Access Controls and Responsible Release — `@ch26-access`

## `p6--applications.qmd`
- Part VI: Clinical Translation — — *.unnumbered*

## `p6-ch27-clinical-risk.qmd`
- Clinical Risk Prediction — `@ch27-clinical-risk`
    - From Polygenic Scores to Foundation Model Features — `@ch27-pgs-to-fm`
    - Defining Clinical Risk Prediction — `@ch27-defining-risk`
    - Feature Integration Architectures — `@ch27-feature-integration`
    - EHR Integration and Phenotype Embeddings — `@ch27-ehr-integration`
        - EEPRS Framework — `@ch27-eeprs`
        - Understanding When Embeddings Help — `@ch27-embeddings-help`
        - PRS-PheWAS for Clinical Interpretation — `@ch27-prs-phewas`
        - Implementation Considerations — `@ch27-eeprs-implementation`
        - Integration with Foundation Model Features — `@ch27-eeprs-fm`
    - Temporal Modeling Architectures — `@ch27-temporal-modeling`
    - Evaluation for Clinical Deployment — `@ch27-evaluation`
        - Discrimination — `@ch27-discrimination`
        - Calibration — `@ch27-calibration`
        - Clinical Utility — `@ch27-clinical-utility`
        - Validation Hierarchy — `@ch27-validation-hierarchy`
    - Uncertainty Quantification — `@ch27-uncertainty`
    - Fairness and Health Equity — `@ch27-fairness`
    - Clinical Integration — `@ch27-clinical-integration`
        - Workflow Integration Patterns — `@ch27-workflow-patterns`
        - System Architecture — `@ch27-system-architecture`
        - Post-Deployment Monitoring — `@ch27-monitoring`
    - Regulatory and Quality Frameworks — `@ch27-regulatory`
    - Case Studies — `@ch27-case-studies`
        - Cardiometabolic Risk Stratification — `@ch27-case-cardio`
        - Oncology Prognosis — `@ch27-case-oncology`
        - Pharmacogenomic Adverse Event Prediction — `@ch27-case-pharmacogenomics`
    - Translation as the Test — `@ch27-translation-test`

## `p6-ch28-rare-disease.qmd`
- Rare Disease Diagnosis — `@ch28-rare-disease`
    - Variant Prioritization Funnel — `@ch28-prioritization-funnel`
        - Quality and Technical Filters — `@ch28-quality-filters`
        - Population Frequency Filters — `@ch28-frequency-filters`
        - Consequence and Gene Filters — `@ch28-consequence-filters`
        - Foundation Model Scoring — `@ch28-fm-scoring`
    - ACMG-AMP Criteria and Computational Evidence — `@ch28-acmg-amp`
        - Evidence Categories — `@ch28-evidence-categories`
        - PP3 and BP4: Computational Evidence — `@ch28-pp3-bp4`
        - Calibrating Predictions to Evidence Strength — `@ch28-calibration`
    - Family-Based Analysis — `@ch28-family-analysis`
        - *De Novo* Variants — `@ch28-de-novo`
        - Compound Heterozygosity and Phasing — `@ch28-compound-het`
        - Segregation Analysis — `@ch28-segregation`
    - Somatic Variant Interpretation in Cancer — `@ch28-somatic`
        - Germline versus Somatic Distinction — `@ch28-germline-somatic`
        - Driver Classification — `@ch28-driver`
        - Therapeutic Biomarkers — `@ch28-biomarkers`
    - Laboratory Validation — `@ch28-validation`
        - Types of Functional Assays — `@ch28-assay-types`
        - Integrating Functional Evidence — `@ch28-functional-integration`
        - Closing the VUS Loop — `@ch28-vus-loop`
    - Practical Workflow Integration — `@ch28-workflow`
        - Laboratory Workflow — `@ch28-lab-workflow`
        - Clinical Decision-Making — `@ch28-clinical-decisions`
        - Regulatory and Ethical Considerations — `@ch28-regulatory`
    - Interpretive Partnership — `@ch28-partnership`

## `p6-ch29-drug-discovery.qmd`
- Drug Discovery — `@ch29-drug-discovery`
    - Genetic Foundation of Target Selection — `@ch29-genetic-foundation`
        - From Variant-Level Predictions to Gene-Level Evidence — `@ch29-variant-to-gene`
        - Linking Genetics to Target Safety and Efficacy — `@ch29-safety-efficacy`
    - Network-Aware Target Discovery and Repurposing — `@ch29-network-discovery`
        - Propagating Genetic Signals Through Networks — `@ch29-network-propagation`
        - Drug Repurposing Through Shared Representations — `@ch29-repurposing`
    - Drug-Target Interaction Prediction — `@ch29-dti-prediction`
        - Representing Targets for Binding Prediction — `@ch29-binding-prediction`
        - Selectivity and Off-Target Prediction — `@ch29-selectivity`
    - Toxicity Prediction from Genomic Context — `@ch29-toxicity`
        - Genetic Evidence of Target Liabilities — `@ch29-genetic-liabilities`
        - Expression-Based Toxicity Prediction — `@ch29-expression-toxicity`
        - Integrating Genomic Context with Chemical Properties — `@ch29-integrated-toxicity`
    - Functional Genomics Screens and Perturbation Models — `@ch29-functional-screens`
        - Designing Informative Perturbation Libraries — `@ch29-library-design`
        - Perturb-seq and Transcriptomic Readouts — `@ch29-perturb-seq`
        - Closing the Loop: Lab-in-the-Loop Refinement — `@ch29-lab-in-loop`
    - Biomarker Development and Patient Stratification — `@ch29-biomarkers`
        - Foundation Model Features for Stratification — `@ch29-stratification-features`
        - Multi-Omic Biomarker Discovery — `@ch29-multi-omic-biomarkers`
        - Trial Design and Endpoint Selection — `@ch29-trial-design`
    - Industry Workflows and Infrastructure — `@ch29-industry-workflows`
        - Building Model Infrastructure — `@ch29-model-infrastructure`
        - Strategic Choices: Build, Buy, or Fine-Tune — `@ch29-build-buy-finetune`
        - Industry Context: Timelines and Decision Gates — `@ch29-timelines`
        - Intellectual Property and Data Considerations — `@ch29-ip-data`
    - Evaluation and Validation — `@ch29-evaluation`
        - Benchmark Limitations — `@ch29-benchmark-limits`
        - From Prediction to Validation — `@ch29-prediction-validation`
    - Connections to Molecular Design — `@ch29-molecular-design`
    - Prioritization, Not Automation — `@ch29-conclusion`

## `p6-ch30-design.qmd`
- Sequence Design — `@ch30-design`
    - Design Formalism — `@ch30-formalism`
    - Protein Design with Language Models — `@ch30-protein-design`
        - Sequence Generation from Language Model Priors — `@ch30-plm-generation`
        - Structure-Aware Design with Diffusion Models — `@ch30-structure-diffusion`
        - Functional Conditioning and Multi-Objective Optimization — `@ch30-multi-objective`
    - Regulatory Sequence Design — `@ch30-regulatory-design`
        - Promoter and Enhancer Engineering — `@ch30-promoter-enhancer`
        - Splicing and RNA Processing Elements — `@ch30-splicing-design`
    - mRNA Design and Optimization — `@ch30-mrna-design`
        - Codon Optimization Principles — `@ch30-codon-optimization`
        - Stability Engineering and UTR Design — `@ch30-utr-design`
        - Immunogenicity Considerations — `@ch30-mrna-immunogenicity`
    - Antibody and Vaccine Design — `@ch30-antibody-vaccine`
        - CDR Optimization and Humanization — `@ch30-cdr-optimization`
        - Vaccine Antigen Design — `@ch30-vaccine-design`
    - Closed-Loop Design-Build-Test-Learn Cycles — `@ch30-dbtl`
        - Active Learning for Efficient Exploration — `@ch30-active-learning`
        - High-Throughput Experimentation Integration — `@ch30-high-throughput`
    - Validation Requirements and Failure Modes — `@ch30-validation`
        - Validation Hierarchy — `@ch30-validation-hierarchy`
        - Characteristic Failure Patterns — `@ch30-failure-patterns`
    - Practical Design Constraints — `@ch30-practical-constraints`
        - Manufacturing and Developability — `@ch30-manufacturing`
        - Safety and Biosecurity Considerations — `@ch30-biosecurity`
    - Algorithmic Search and Optimization — `@ch30-algorithms`
    - From Understanding to Creating — `@ch30-conclusion`

## `p6-ch31-frontiers.qmd`
- Frontiers and Synthesis — `@ch31-frontiers`
    - Open Technical Problems — `@ch31-technical`
        - Scaling and Efficiency — `@ch31-scaling`
        - Context and Multi-Scale Integration — `@ch31-multiscale`
        - Causality and Mechanism — `@ch31-causality`
    - Emerging Directions — `@ch31-emerging`
        - Multimodal Integration — `@ch31-multimodal`
        - Agentic and Closed-Loop Systems — `@ch31-agentic`
        - Clinical Integration and Learning Health Systems — `@ch31-learning-health`
    - Work Ahead — `@ch31-conclusion`
